Status:

RECRUITING

Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

Lead Sponsor:

University of Coimbra

Conditions:

Temporomandibular Joint Disorder

Eligibility:

All Genders

18+ years

Brief Summary

t is recognized that cortisol, a hormone produced by the adrenal glands, is a marker that is elevated in patients with psychological disorders, particularly anxiety. On the other hand, Temporomandibul...

Eligibility Criteria

Inclusion

  • Patients who attend the dental clinic of the Faculty of Medicine of University of Coimbra

Exclusion

  • Pregnant women, minors and non-autonomous individuals

Key Trial Info

Start Date :

September 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 30 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06874868

Start Date

September 15 2024

End Date

May 30 2025

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicine of University of Coimbra

Coimbra, Coimbra District, Portugal, 3000-075

Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder | DecenTrialz